GSK and Gilead Sciences received multiple approvals for pipeline products and benchmarked performance against competitors.

1 report, 1 independent Updated Sep 5

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

GSK Gilead Sciences FDA

Keep exploring

Part of

GSK and EXEL are developing treatments for PBC, and the FDA granted accelerated approval to Gilead Sciences for related therapies. All 1 developments

The entities involved

GSK
British multinational pharmaceutical and biotechnology company
- Uncertainty over a dispute involving GSK and AnaptysBio weighed on market sentiment.Sat 23:22
- FDA approved a GSK drug and authorized a Roche blood test for eligibility, amidst estimates of 1.7M chronic HBV patients in the US.Fri 12:54
Gilead Sciences
company in Madrid, Spain

Nothing else this week.
FDA
- FDA removed warnings from HRT products, and a meeting is scheduled in Chicago involving researchers from Clalit Health Services.05:51
- Benchmark and Jefferies reaffirmed buy ratings while the FDA cited toxicity findings for Bright Minds Biosciences Inc.04:52

Coverage

Newest first; wire copies grouped

Sep 5fool.com